Asian press release distribution

Press Releases for Thursday, June 8, 2023

International Confederation of Midwives to Host Thousands of Delegates at Its 33rd Triennial Congress in Bali 23:00 HKT/SGT

Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, progresses at full speed in innovative research and development, Presents major research results of birociclib, the start product, at the international stage in ASCO 21:18 HKT/SGT

四环医药旗下轩竹生物创新研发全速前进携明星产品吡罗西尼重磅研究成果登国际舞台于ASCO亮相 21:16 HKT/SGT

四環醫藥旗下軒竹生物創新研發全速前進攜明星產品吡羅西尼重磅研究成果登國際舞台於ASCO亮相 21:15 HKT/SGT

Doubleview Resumes Diamond Drilling Exploration at Hat Project 21:05 HKT/SGT

Doubleview Resumes Diamond Drilling Exploration at Hat Project 21:00 HKT/SGT

Hitachi launches "Hitachi Application Reliability Centers Service" in Japan to enable cloud-native operations to drive both agility and reliability 15:50 HKT/SGT

The Philippines' top-line cybersecurity event, PhilSec now backed by CyberSecurity Philippines CERT & WiSAP 14:07 HKT/SGT

Internationally Acclaimed Benns Chocolate Launches Single-Origin Chocolate Evoking Malaysian Flavours 14:00 HKT/SGT

LEXUS、「LC」を一部改良するとともに特別仕様車“EDGE”を発売 13:30 HKT/SGT

Eisai Files Marketing Authorization Application for Lecanemab as Treatment For Early Alzheimer's Disease in South Korea 12:32 HKT/SGT

Famed Photographer David Christopher Lee to Give Away NFTs of Iconic Photos Over the Month of June 09:47 HKT/SGT

エーザイ、抗アミロイドβプロトフィブリル抗体「レカネマブ」について、韓国において早期アルツハイマー病に係る適応で新薬承認を申請 09:00 HKT/SGT

Taiwan Excellence Showcases over 30 Award-Winning Products at Asia Tech x Singapore 2023 Debut 09:00 HKT/SGT

Empower Your Journey: BLUETTI AC60 Redefines Portable Energy for the Aussie Explorer 09:00 HKT/SGT

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer's Disease 06:26 HKT/SGT

ACN Search:


CleverTap's 2024 Market Research Report Unveils that Brands Implementing Higher AI Adoption See 4x Boost in Conversions


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575